medicaldevices

  It is estimated that   congenital genu recurvatum Market  is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023. Genu recurvatum is also known as knee hyperextension or back knee. It is a type of condition that affects the knee joint to bend backward when the person is in standing position. This problem is more common in women than in men and commonly identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). This condition leads to stress in the posterior knee structures and anterior cruciate ligaments (ACL) which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies. Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is extremel

  Multiple Sclerosis Treatment Market-Overview The upsurge in chronic and fatal diseases such as multiple sclerosis has given rise to the demand for its treatment options. Reports created by MRFR detail the developments of the industry that can be expected in the market through the forecast period. The  Multiple Sclerosis Treatment Market Size  is estimated to show a 3.5% CAGR during the forecasted period. The focus of the treatment options to slow down the progression of diseases and managing MS symptoms is predicted to yield substantial results in the forecast period. The escalation in funding available to multiple sclerosis treatment companies is estimated to usher in a new chapter in the overall development of the global multiple sclerosis treatment market in the forecast period. Segmental Analysis The segmental overview of the multiple sclerosis treatment market is conducted on the basis of drug type, end-user, region, diagnosis. The drug type segment of the multiple sclerosis tre